FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Eprosartan Mesylate Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Mylan Pharmaceuticals Inc. (Revised 03/16/2020)

Company Contact Information:

Presentation Posting Date Related Information
Eprosartan Mesylate 600mg T 30s (NDC 0378-6629-93) 03/16/2020 Mylan has made a business decision to discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English